Researchers evaluate whether ultra-processed food and Mediterranean diet scores were associated with frailty and cardiometabolic disease in older adults.
Novel Agent for Chronic GVHD Wins FDA Approval
The FDA approved the colony stimulating factor-1 receptor (CSF-1R) inhibitor axatilimab (Niktimvo) for chronic graft-versus-host-disease (cGVHD) that has failed two prior lines of systemic therapy.